Clinical presentation of tuberculoid leprosy in an epidermodysplasia verruciformis patient.

Epidermodysplasia verruciformis (EV) is triggered by a variety of mechanisms that at least partly include genetic background. We present a Brazilian man with a 30-year history of flat, wart-like lesions with clinical, histopathological, and evolutive aspects consistent with papillomavirus (HPV)-associated EV. Histological analysis of the wart lesions showed epidermis with hyperkeratosis, regular acanthosis, hypergranulosis, and cells with abundant basophilic cytoplasm. Moreover, a perivascular lymphocytic infiltrate was found in the superficial dermis, consistent with a viral wart. Type-2-HPV DNA was detected in various fragments of skin-wart lesions using the polymerase chain reaction (PCR). Two years after the EV diagnosis, the patient presented with an anesthetic well-demarcated, erythematous and mildly scaly plaque on his right forearm. A histopathological analysis of this lesion demonstrated the presence of a compact tuberculoid granuloma. Ziehl-Neelsen staining demonstrated the presence of rare acid-fast bacilli and confirmed the tuberculoid leprosy diagnosis. The patient's Mitsuda Intradermal Reaction was positive. To elucidate the possible mechanism involved in this case of EV, we genotyped the HLA genes of this patient. DQB genotyping showed the polymorphic HLA alleles DQB1*0301 and 0501. The patient was treated with a paucibacillary multi-drug therapy scheme, and the disease was cured in six months. This report describes an EV patient with an M. leprae infection, confirming that tuberculoid leprosy patients possess a relatively specific and efficient cell-mediated immunity against the bacillus and, therefore, localized forms of the disease. Moreover, we show the possible involvement of the polymorphic HLA alleles DQB1*0301 and 0501 in EV induction mechanisms.

[1]  B. Vasudevan,et al.  Immune reconstitution inflammatory syndrome in leprosy. , 2011, Indian journal of leprosy.

[2]  G. Orth [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model]. , 2010, Bulletin de l'Academie nationale de medecine.

[3]  I. Leigh,et al.  Vulval intraepithelial neoplasia and periungual Bowen's disease concordant for mucosal (HPV‐34) and epidermodysplasia verruciformis (HPV‐21) human papillomavirus types , 2007, Clinical and experimental dermatology.

[4]  G. Orth Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. , 2006, Seminars in immunology.

[5]  Diana J L Williams,et al.  The Continuing Challenges of Leprosy , 2006, Clinical Microbiology Reviews.

[6]  T. Ortak,et al.  Epidermodysplasia Verruciformis: An Unusual Presentation , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[7]  K. Kariya,et al.  A genotype distribution of human papillomaviruses detected by polymerase chain reaction and direct sequencing analysis in a large sample of common warts in Japan , 2005, Journal of medical virology.

[8]  A. Rübben,et al.  Human leukocyte antigen class II alleles and natural history of HPV 2/27/57-induced common warts , 2004, Archives of Dermatological Research.

[9]  S. Holland,et al.  Recurrent ‘sterile’ verrucous cyst abscesses and epidermodysplasia verruciformis‐like eruption associated with idiopathic CD4 lymphopenia , 2003, The British journal of dermatology.

[10]  T. Rohan,et al.  Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. , 2002, The Journal of infectious diseases.

[11]  B. Autran,et al.  Epidermodysplasia verruciformis‐like eruption complicating human immunodeficiency virus infection , 1998, The British journal of dermatology.

[12]  C. Peyton,et al.  Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. , 1994, The Journal of infectious diseases.

[13]  A. Simpson,et al.  Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. , 1994, BioTechniques.

[14]  H. Tagami,et al.  Epidermodysplasia verruciformis accompanied by familial large granular lymphocytosis and a decrease in T lymphocytes. , 1993, Acta dermato-venereologica.

[15]  H. Pfister Biologie der Epidermodysplasia-verruciformis-assoziierten HPV , 2010, Der Hautarzt.

[16]  W. Lechner,et al.  Epidermodysplasia verruciformis in lepromatous leprosy. Report of 2 cases. , 1984, Dermatologica.